Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 4, Issue 1, 2008, Pages 41-48

  Jain, Sanjay K ^a   Gupta, Yashwant ^a   Jain, Anekant ^a   Saxena, Asheesh R ^a   Khare, Piush ^a   Jain, Aviral ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Anti HIV; Didanosine; Gelatin nanoparticles; Mannose; Mannosylated nanoparticles

Indexed keywords

DRUG DELIVERY; FLUORESCENCE; GELATION; IMMUNOLOGY; MAGNETIC RESONANCE SPECTROSCOPY; NANOPARTICLES; PROTEINS; VIRUSES;

DIDANOSINES; DRUG ENTRAPMENT; DRUG PAYLOADS; MANNOSES; MANNOSYLATED NANOPARTICLES; UNCONJUGATED NANOPARTICLES;

MEDICAL NANOTECHNOLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; GELATIN; MANNOSE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; FLUORESCENCE ANALYSIS; INFRARED SPECTROSCOPY; LIVER; LUNG; LYMPH NODE; MACROPHAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; ZETA POTENTIAL;

ANIMALS; DIDANOSINE; DRUG CARRIERS; GELATIN; MACROPHAGES, ALVEOLAR; MALE; MANNOSE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE INHIBITORS; TISSUE DISTRIBUTION;

EID: 40049100942     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2007.11.004     Document Type: Article

References (30)

1. Takakura Y., and Hashida M. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm Res 13 (1996) 820-831
2. Auger MJ, Ross JA. The biology of the macrophage in the natural immune system: the macrophage. In: Lewis CE, Mcgee HOD, editors. Oxford: Oxford University Press; 1992. pp. 1-7.
3. Levy J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57 (1993) 183-289
4. Weiss R.A. How does HIV cause AIDS. Science 260 (1993) 1273-1279
5. Largent B.L., Walton K.M., Hoppe C.A., Lee Y.C., and Schnaar R.L. Carbohydrate-specific adhesion of alveolar macrophages to mannose derivatized surfaces. J Biol Chem 259 (1984) 1764-1769
6. Haltiwanger R.S., and Hill R.L. The ligand binding specificity and tissue localization of a rat alveolar macrophage lectin. J Biol Chem 261 (1986) 15696-15702
7. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Del Rev 54 (2002) 631-651
8. Sakuma H., and Ohshima T.K. Binding constants of metal cations to and Hamaker constant for poly(N,N-lysine diylterephthaloyl) microcapsules. J Colloid Interface Sci 135 (1990) 455-460
9. Hans M.L., and Lowman A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6 (2002) 319-327
10. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev 55 (2003) 329-347
11. Nakada Y., Fattal E., Foulquier M., and Couvreur P. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm Res 13 (1996) 37-43
12. Sakuma S., Sudo R., Suzuki N., Kikuchi H., Akashi M., and Hayashi M. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int J Pharm 177 (1999) 161-172
13. Ammoury N., Fessi H., Devissaguet J.P., Dubrasquet M., and Benita S. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Pharm Res 8 (1991) 101-105
14. Grangier J.L., Puygrenier M., Gautier J.C., and Couvrear P. Nanoparticles as carriers for growth hormone releasing factor. J Control Rel 15 (1991) 3-13
15. Hamdi G., Ponchel G., and Duchene D. An original method for studying in vitro the enzymatic degradation of cross-linked starch microspheres. J Control Rel 55 (1998) 193-201
16. Andrianov A.K., and Payne L.G. Polymeric carriers for oral uptake of microparticulates. Adv Drug Deliv Rev 34 (1998) 155-170
17. Schwick H.G., and Heide K. Immunochemistry and immunology of collagen and gelatin. Bibl Haematol 3 (1969) 111-125
18. Ward A.G., and Courts A. The cience and technology of gelatin (1977), Academic Press, New York
19. Mladenovska K., Kumbaradzi E.F., Dodov G.M., Makraduli L., and Goracinova K. Biodegradation and drug release studies of BSA loaded gelatin microspheres. Int J Pharm 242 (2002) 247-249
20. Coester C.J., Nayyare P., and Samuel J. In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localization. Eur J Pharm Biopharm 62 (2006) 306-314
21. Mitchell J.P., Roberts D.R., Langley J., Koentgen F., and Lambert J.N. A direct method for the formation of peptide and carbohydrate dendrimers. Bioorg Med Chem Lett 9 (1999) 2785-2788
22. Leo E., Vandelli M.A., Cameroni R., and Forni F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int J Pharm 155 (1997) 75-82
23. Gupta Y., Soni V., Chourasia M.K., Jain A., Khare P., and Jain S.K. Targeted drug delivery to the brain via transferrin coupled liposomes. Drug Deliv Tech 5 (2005) 66-71
24. Liang W.W.X., Deshpande D., Malanga C.J., and Rojanasakul Y. Oligonucleotide targeting to alveolar macrophages by mannose receptor mediated endocytosis. Biochim Biophys Acta 1279 (1996) 227-233
25. Oliveira A.M.C., Lowena T.C.R., Cabral L., Santos M.E.M., Rodrigues C.R., Castro H.C., and Santos T.C. Development and validation of a HPLC-UV method for the determination in didanosine tablets. J Pharm Biomed Analysis 38 (2005) 751-756
26. Gupta Y., Jain A., and Jain S.K. Transferrin conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59 7 (2007) 935-940
27. Gupta Y, Jain A, Jain P, Jain SK. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumour cells. J Drug Target. 2007;15:231-40.
28. Marty J.J., Oppenheim R.C., and Speiser P. Nanoparticles: a new colloidal drug delivery system. Pharm Acta Helveticae 53 (1978) 17-23
29. Coester CJ, Langer K, Von Briesen H, Kreuter J. Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptake. J Microencap 2000;17:187-93.
30. Holland S.J., and Tighe B.J. Biodegradable polymers. In: Garderton D., and Jones T. (Eds). Advanced pharmaceutical sciences vol. 6 (1992), Academic Press, New York 101-164